Related Experiment Video
Updated: Aug 2, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
A single-patient-use ECG system for cardiothoracic surgery admissions in the UK: A cost-consequence analysis
Rhodri Saunders1, Marco Caterino1, Pranav Somaiya1,2
1Coreva Scientific GmbH & Co KG, Königswinter, Nordrhein-Westfalen, Germany.
Insights
Single-patient ECG devices (spECG) reduce deep sternal wound infections and associated costs in coronary artery bypass grafting (CABG) patients. This study shows spECG offers significant savings and improved patient safety in NHS cardiac units.
Area of Science:
- Cardiovascular Surgery
- Infection Control
- Health Economics
Background:
- Deep sternal wound infections (DSWI) are a significant complication post-coronary artery bypass grafting (CABG), occurring in up to 1.36% of UK procedures.
- Each DSWI event incurs substantial additional healthcare costs (£4,000-£11,000) primarily due to extended hospital stays.
- Reusable ECG devices may transmit infections during perioperative care, while single-patient ECG devices (spECG) show potential for reducing surgical site infections (SSI).
Purpose of the Study:
- To estimate the economic and clinical impact of implementing single-patient ECG devices (spECG) in UK National Health Service (NHS) cardiac units.
- To assess the cost-consequence analysis of spECG versus reusable ECG (rECG) devices in the context of CABG procedures.
Main Methods:
- A cost-consequence analysis was performed using a probabilistic, individual-patient simulation model (Simul8 software) of the UK CABG care pathway.
- The simulation modeled 2,183 patients over 1 year, incorporating demographic and clinical data from NHS Digital, and assessed SSI risk using the Brompton Harefield Infection Score (BHIS).
- The base case simulation reflected the Bart Health NHS Trust cardiac unit, with results averaged across 50 iterations.
Main Results:
- The simulation indicated a cost saving of £388 per patient with spECG compared to rECG (£12,708 vs £13,096 mean cost).
- Implementation of spECG led to a reduction in overall SSI incidence from 8.6% with rECG to 6.9% with spECG.
- Model sensitivity analysis revealed that general ward and ICU costs, and infection incidence were more influential on per-patient savings than CABG procedure volume.
Conclusions:
- Single-patient ECG devices (spECG) represent a sustainable and effective alternative to reusable ECG cables and lead wires in cardiac surgery.
- spECG adoption can enhance patient safety by reducing SSI incidence and offers improved resource allocation within NHS cardiac units.
Background:
Deep sternal wound infections (DSWI) are severe complications in up to 1.36% of coronary artery bypass grafting (CABG) procedures in the United Kingdom. Each event adds between £4,000 and £11,000 in healthcare costs, owing primarily to prolonged hospitalisations. ECG devices have been shown to convey infection throughout perioperative CABG. On the other hand, single-patient ECG devices (spECG) can effectively reduce the incidence of surgical site infections (SSI), including DSWI, but no assessment of spECG impact in NHS cardiac units has been conducted.
Methods:
To estimate the impact of spECG on NHS cardiac units, we conducted a cost-consequence analysis modeling the CABG care pathway in the United Kingdom using Simul8 software for a probabilistic, individual-patient simulation. The simulation time was 1 year, with each patient followed from admission through 30 days post-discharge. The base case simulation mirrors the cardiac unit of Bart Health NHS Trust, London. A total of 2,183 patients are generated with demographic and clinical attributes from probabilistic distributions informed by hospital-specific inputs from NHS Digital Data. The Brompton Harefield Infection Score (BHIS) is allocated to gauge the risk of SSI. Results are averaged across 50 independent and randomly seeded iterations.
Results:
Simulation results indicate a base-case savings of £388 per patient, determined by the incidence of infections rather than the number of CABG procedures. In the base-case simulation, the mean cost of care with rECG was £13,096, whereas the mean cost with spECG was £12,708, resulting in a cost saving of £388 (2021 GBP). The simulation yielded an overall 8.6% SSI incidence rECG, whereas the incidence of SSIs with spECG was 6.9%. The model was most sensitive to changes in general ward and ICU costs, and infection incidence was a stronger predictor of potential per-patient savings than annual CABG volume.
Conclusion:
Single-patient ECG is a sustainable and effective alternative to reusable ECG cables and lead wires in terms of patient safety and resource allocation.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Holter Monitor: 24-Hour Monitoring
Electrocardiogram Fundamentals
An electrocardiogram (ECG) is a diagnostic tool for identifying cardiac conditions such as arrhythmias, conduction abnormalities, and myocardial ischemia.
Definition
An electrocardiogram (ECG) visualizes the heart's electrical activity by tracing the electrical movement associated with each heartbeat on a graph or monitor. As the heart beats, an electrical wave passes through it, correlating with the cardiac cycle events.
Parts of an ECG
An ECG utilizes electrodes on the skin...
Cardiac Catheterization I: Pre-Procedure Overview
Dysrhythmias V: Evaluating Dysrhythmias